Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

I.S. van Houdt, B.J.R. Sluijter, L.M. Moesbergen, W. Vos, T.D. de Gruijl, B.G. Molenkamp, A.J.M. van den Eertwegh, E. Hooijberg, P.A.M. van Leeuwen, C.J.L.M. Meijer, J.J. Oudejans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)609-615
JournalInternational Journal of Cancer
Issue number3
Publication statusPublished - 2008

Cite this